PCH
SUPN icon

Polar Capital Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History

Polar Capital Holdings’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,002,340
Closed -$31.6M – 294
2025
Q2 		$31.6M Sell
1,002,340
-360,000
-26% -$11.5M 0.17% 114
2025
Q1 		$44.6M Sell
1,362,340
-325,590
-19% -$11.5M 0.27% 104
2024
Q4 		$61M Sell
1,687,930
-250,000
-13% -$8.8M 0.34% 75
2024
Q3 		$60.4M Sell
1,937,930
-2,580
-0.1% -$80.5K 0.29% 75
2024
Q2 		$51.9M Hold
1,940,510
– – 0.31% 82
2024
Q1 		$66.2M Buy
1,940,510
+1,145
+0.1% +$34.1K 0.35% 71
2023
Q4 		$56.1M Buy
1,939,365
+284,895
+17% +$7.55M 0.34% 82
2023
Q3 		$45.6M Buy
1,654,470
+150,000
+10% +$4.57M 0.34% 80
2023
Q2 		$45.2M Buy
1,504,470
+117,055
+8% +$4.1M 0.23% 91
2023
Q1 		$50.3M Buy
1,387,415
+368,295
+36% +$14.2M 0.33% 84
2022
Q4 		$36.4M Buy
1,019,120
+225,000
+28% +$7.82M 0.29% 105
2022
Q3 		$26.9K Hold
794,120
– – 0.17% 116
2022
Q2 		$23K Sell
794,120
-83,825
-10% -$2.4M 0.13% 131
2022
Q1 		$28.4K Buy
877,945
+250,000
+40% +$7.66M 0.13% 136
2021
Q4 		$18.3K Buy
+627,945
New +$19.1M 0.07% 177

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Polar Capital Holdings's SUPN Position: Q3 2025 in Review

Polar Capital Holdings sold out of Supernus Pharmaceuticals (SUPN) in Q3 2025, closing a stake of 1,002,340 shares — an estimated $31.6M sold.

Polar Capital Holdings first reported a position in SUPN in Q4 2021 and held it in 15 quarters. The position peaked at $66.2M in Q1 2024. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

  • Polar Capital Holdings reported no remaining Supernus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 1,002,340 Supernus Pharmaceuticals shares in Q3 2025, an estimated $31.6M.
  • Polar Capital Holdings first reported a position in Supernus Pharmaceuticals in Q4 2021 and held it in 15 quarters.
  • Polar Capital Holdings's Supernus Pharmaceuticals position peaked at $66.2M in Q1 2024.
  • 310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on Polar Capital Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.